Zobrazeno 1 - 10
of 357
pro vyhledávání: '"Klaus Wiedemann"'
Autor:
Klaus Wiedemann
Dieses Open-Access-Buch untersucht, inwieweit Anbieter im Online-Vertrieb das technische Erkenntnisverfahren Profiling zum Zwecke der Preispersonalisierung einsetzen und welche rechtlichen Rahmenbedingungen dabei gelten. Preispersonalisierung liegt v
Autor:
Oloruntoba Oluboka, Guerline Clerzius, Wolfgang Janetzky, Daniel Schöttle, François Therrien, Klaus Wiedemann, Marc-André Roy
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Functional impairment affects many patients with schizophrenia. Treatment with the long-acting injectable antipsychotic aripiprazole once-monthly (AOM) may help improve functioning. Objectives To explore changes in functioning in
Externí odkaz:
https://doaj.org/article/b41414ee9b7c4325967bcb2efd486c17
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Patients with schizophrenia may benefit from treatment with long-acting injectable (LAI) formulations of antipsychotics. Aripiprazole once-monthly (AOM) is an LAI that was tested in two non-interventional studies in Germany and Ca
Externí odkaz:
https://doaj.org/article/de155861bc4d44d0be483f5b7bf650f5
Autor:
Daniel Schöttle, Wolfgang Janetzky, Daniel Luedecke, Elmar Beck, Christoph U. Correll, Klaus Wiedemann
Publikováno v:
BMC Psychiatry, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background In this non-interventional study, the functionality and well-being of patients with schizophrenia with aripiprazole once-monthly (AOM) was evaluated under real-life conditions in a naturalistic population. Methods This non-interve
Externí odkaz:
https://doaj.org/article/2347a00e9dc646099279114b19eccb93
Autor:
Daniel Schöttle, Guerline Clerzius, Wolfgang Janetzky, Oloruntoba Oluboka, Marc-André Roy, François Therrien, Klaus Wiedemann
Publikováno v:
European Psychiatry, Vol 65 (2022)
AbstractBackgroundNoninterventional naturalistic studies are an important complement to randomized controlled trials. Aripiprazole once-monthly (AOM) is an atypical antipsychotic in a long-acting injectable formulation.MethodsA pooled analysis of two
Externí odkaz:
https://doaj.org/article/c1f5b4ef65794bbd9a012797acb20b7e
Publikováno v:
Journal of Psychiatric Research. 161:449-454
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f29c272b8b700d5b2b2a51f17ccb4b6
https://doi.org/10.1016/j.jpsychires.2023.04.003
https://doi.org/10.1016/j.jpsychires.2023.04.003
Autor:
Niels Hansen, Michael Lipp, Jonathan Vogelgsang, Ruth Vukovich, Tristan Zindler, Daniel Luedecke, Stefan Gingele, Berend Malchow, Helge Frieling, Simone Kühn, Johannes Denk, Jürgen Gallinat, Thomas Skripuletz, Nicole Moschny, Jens Fiehler, Christian Riedel, Klaus Wiedemann, Mike P. Wattjes, Inga Zerr, Hermann Esselmann, Stefan Bleich, Jens Wiltfang, Alexandra Neyazi
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 9, Iss , Pp 100154- (2020)
Background: Autoimmune-mediated encephalitis is a disease that often encompasses psychiatric symptoms as its first clinical manifestation’s predominant and isolated characteristic. Novel guidelines even distinguish autoimmune psychosis from autoimm
Externí odkaz:
https://doaj.org/article/492aed4140b143cfa58a507c7af5a953
Autor:
Michael Kaczmarczyk, Carsten Spitzer, Katja Wingenfeld, Klaus Wiedemann, Linn K. Kuehl, Katharina Schultebraucks, Christian Eric Deuter, Christian Otte
Publikováno v:
European Journal of Psychotraumatology, Vol 11, Iss 1 (2020)
Background: Adverse childhood experiences (ACE) are associated with an increased risk of major depressive disorder (MDD) and hypothalamic-pituitary-adrenal (HPA) axis dysregulation. Within the HPA axis, corticotropin-releasing hormone and vasopressin
Externí odkaz:
https://doaj.org/article/0984996fe9764b088834f4f56de0b63e
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
BackgroundMajor depressive disorder (MDD) constitutes the leading cause of disability worldwide. Although efficacious antidepressant pharmacotherapies exist for MDD, only about 40–60% of the patients respond to initial treatment. However, there is
Externí odkaz:
https://doaj.org/article/09945bb9fa1e4dfa979ae35b087094ed
Autor:
Daniel Schöttle, Wolfgang Janetzky, Daniel Luedecke, Elmar Beck, Christoph U. Correll, Klaus Wiedemann
Publikováno v:
BMC Psychiatry, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background In this study, the treatment of schizophrenia patients with aripiprazole once-monthly (AOM) was evaluated under real-life conditions in a naturalistic setting. Methods This multicenter, prospective, non-interventional study includ
Externí odkaz:
https://doaj.org/article/41c3909ba52e44cd8a6c69762115fa48